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The C-type mannose receptor and its homolog
Endo180 (or uPARAP, for urokinase plasminogen
activator receptor-associated protein) mediate the
endocytic uptake of collagen bymacrophages and fi-
broblasts. This process is required for normal tissue
remodeling, but also facilitates the growth and
dissemination of tumors. We have determined the
crystal structure at 2.5 A˚ resolution of the N-terminal
region of Endo180, consisting of a ricin-like domain,
a fibronectin type II (FN2) domain, and two C-type
lectin (CTL) domains. The L-shaped arrangement of
these domains creates a shallow trench spanning
the FN2 and CTL1 domains, which was shown by
mutagenesis to bind triple-helical and denatured
collagen. Small-angle X-ray scattering showed that
the L-shaped structure is maintained in solution at
neutral and acidic pH, irrespective of calcium ion
loading. Collagen binding was equally unaffected
by acidic pH, suggesting that collagen release in en-
dosomes is not regulated by changes within the
Endo180 N-terminal region.
INTRODUCTION
Collagens are a major component of extracellular matrix and are
essential for tissue stability. Fibrillar collagens, such as type I
collagen, are found in interstitial matrices and form highly or-
dered suprastructures in the cornea, skin, tendon, and bone.
The non-fibrillar type IV collagen is an invariant and abundant
component of basement membranes (Kadler et al., 2007). Regu-
lated breakdown of collagen is required for morphogenesis, tis-
sue remodeling, and repair. Perturbed collagen homeostasis is
associated with a range of diseases, including organ fibrosis,
scarring, and arthritis. Furthermore, malignant tumor cells
need to breach collagen-rich matrices to disseminate and
form metastases (Bonnans et al., 2014). The triple-helical struc-
ture and large size of collagens necessitate unique degradation
mechanisms. Collagenolytic matrix metalloproteinases (MMPs)
initially cleave fibrillar collagens at a single site three-quarters
from the N terminus of the triple helix (Fields, 2013). The tripleStruhelices of the resulting fragments unfold at body temperature
(Danielsen, 1987; Gross and Nagai, 1965), and the denatured
collagen fragments are further degraded by a variety of extracel-
lular proteinases or internalized by macrophages and fibroblasts
for lysosomal degradation (Everts et al., 1996; Madsen et al.,
2011).
The major route of non-phagocytic collagen clearance is
through endocytosis by the C-type mannose receptor (MR)
and its homolog Endo180 (also called urokinase plasminogen
activator receptor-associated protein or uPARAP) (East et al.,
2003; Engelholm et al., 2003; Martinez-Pomares et al., 2006;
Wienke et al., 2003). Cultured cells expressing MR or Endo180
take up labeled collagen and route it to lysosomal compartments
for degradation. Cleaved or heat-denatured collagen (gelatin) is
taken up more avidly than intact collagen (Madsen et al.,
2007), and this preference is also observed in binding studies
with purified MR and Endo180 proteins (Martinez-Pomares
et al., 2006; Wienke et al., 2003). The size of fibrillar collagens
far exceeds that of typical endocytic vesicles, and it is unclear
whether intact collagen actually can be endocytosed. Phagocy-
tosis of collagen fibrils is an established phenomenon, however
(Everts et al., 1996).
Mice lacking a functional Endo180 are phenotypically normal,
but fibroblasts derived from these animals are incapable of
collagen uptake (East et al., 2003; Engelholm et al., 2003). The
impaired collagen turnover in Endo180-deficient mice was
shown to reduce tumor growth in a mammary adenocarcinoma
model (Curino et al., 2005). Analysis of MR-deficient mice is
complicated by the additional roles of MR in glycoprotein uptake
and immunity (Lee et al., 2002; Martinez-Pomares, 2012). A
recent study used in vivo imaging to demonstrate MR-depen-
dent uptake of injected labeled collagen by macrophages (Mad-
sen et al., 2013).
MR and Endo180 share a common domain structure with
two other receptors that are not believed to internalize
collagen, phospholipase A2 receptor (PLA2R) and DEC-205
(East and Isacke, 2002). The large extracellular region of each
of these receptors consists of an N-terminal ricin B-like domain,
followed by a fibronectin type II (FN2) domain and eight (MR,
Endo180, PLA2R) or ten (DEC-205) C-type lectin (CTL) do-
mains. The cytoplasmic regions are short and contain endocy-
tosis motifs. FN2 domains in fibronectin and MMPs mediate
gelatin binding (Banyai et al., 1994; Murphy et al., 1994; Pick-
ford et al., 2001), and the same function has been demon-
strated for the FN2 domains of MR (Napper et al., 2006) andcture 23, 2133–2142, November 3, 2015 ª2015 The Authors 2133
Table 1. Crystallographic Statistics of the Endo180 D1-4
Structure
Crystal Form Monoclinic Trigonal
Synchrotron beamline Diamond IO4-1 Diamond IO4
Wavelength (A˚) 0.92 0.98
Space group C2 P3221
Unit cell
a, b, c (A˚) 126.37, 92.37,
127.65
86.99, 86.99,
321.1
a, b, g () 90, 100.31, 90 90, 90, 120
Solvent content (%) 62 59
Resolution range (A˚)a 62.8–2.48
(2.54–2.48)
75.3–3.36
(3.45–3.36)
Rmerge 0.049 (0.481) 0.181 (0.970)
Completeness (%) 97.8 (98.4) 99.4 (99.4)
Multiplicity 3.3 (3.4) 5.5 (5.6)
<I/s(I)> 15.4 (2.2) 10.8 (2.3)
CC1/2 0.994 (0.783) 0.989 (0.635)
Unique reflections 50,150 20,824
Protein atoms 6,960 6,833
Solvent atoms 163 H2O, 4 Na
+, 4 SO4
2–
Rwork 0.194 (0.282) 0.220 (0.320)
Rfree 0.244 (0.314) 0.306 (0.409)
Rmsd bonds (A˚) 0.006 0.005
Rmsd angles () 0.90 0.98
Ramachandran favored (%)b 95.8 93.4
Ramachandran outliers (%)b 0 0
aValues in parentheses are for the highest-resolution shell.
bCalculated with MolProbity (Chen et al., 2010).
Figure 1. Crystal Structure of Endo180 D1-4
(A) Domain organization of Endo180. The plasma membrane is indicated by a
gray bar and the crystallized D1-4 region is colored.
(B) Cartoon representation of the Endo180 D1-4 structure with the ricin-like
domain shown in blue, the FN2 domain in orange, the CTL1 domain in pink,
and the CTL2 domain in green. Disulfide bonds and sodium ions are shown as
yellow sticks and cyan spheres, respectively. The N and C termini are labeled.
The disordered CTL1-CTL2 linker (residues 364–378) is indicated by a
broken line.
See also Figures S1 and S2.Endo180 (Wienke et al., 2003). Why PLA2R and DEC-205 do
not bind and internalize collagen is not entirely clear. A study
using chimeric proteins indicated that they lack critical determi-
nants not only in FN2 but also in the neighboring domains (Ju¨-
rgensen et al., 2014).
The ricin-like domain of MR binds sulfated carbohydrates
(Fiete et al., 1998). The structural basis for this activity, which is
not shared by Endo180 (East et al., 2002), has been revealed
by X-ray crystallography (Liu et al., 2000). Of the eight CTL do-
mains present in MR and Endo180, only CTL4 in MR and CTL2
in Endo180 appear to bind carbohydrates (East et al., 2002; Fein-
berg et al., 2000; Ju¨rgensen et al., 2011). Endo180 binds Ca2+-
dependently to mannose, fucose, and N-acetylglucosamine,
but not to galactose (East et al., 2002). This lectin activity has
been shown to augment the binding of glycosylated collagens
to Endo180 (Ju¨rgensen et al., 2011).
Low-resolution structures of MR and Endo180 have been ob-
tained by electron microscopy (Boskovic et al., 2006; Rivera-
Calzada et al., 2003), but atomic structures of the collagen-bind-
ing regions have been lacking. Here, we present the crystal and
solution structures of domains 1–4 (D1-4) of Endo180 and a
mutational analysis of collagen binding. The FN2 domain is re-
vealed to be integrated into an L-shaped structure that extends
the collagen-binding trench of the FN2 domain into the neigh-
boring CTL1 domain. The overall structure and collagen binding2134 Structure 23, 2133–2142, November 3, 2015 ª2015 The Authorare maintained at pH 5.5 and in the absence of Ca2+, suggesting
that ligand release in endosomes is not regulated by changes
within the D1-4 region of Endo180.
RESULTS
Crystal Structure of Endo180 D1-4
We chose the D1-4 region of Endo180 for our crystallization tri-
als, as it contains both the collagen- and carbohydrate-binding
sites of this receptor (East et al., 2002; Ju¨rgensen et al., 2011).
We obtained two crystal forms of the natively glycosylated
D1-4 region, one of which diffracted to 2.5 A˚ resolution and
allowed the structure to be determined (Table 1). The overall
structure of Endo180 D1-4 is the same in both crystal forms
(the root-mean-square deviations [rmsd] between the four crys-
tallographically independent copies range from 1.2 to 1.4 A˚) and
only the high-resolution structure is described in the following.
The Endo180 D1-4 region adopts an L-shaped structure with a
short arm (60 A˚ length) consisting of the ricin-like and FN2 do-
mains, and a longer arm (80 A˚ length) consisting of the two CTL
domains (Figure 1). The corner of the L is flattened and presents
a contiguous FN2-CTL1 surface that includes FN2 residues pre-
dicted to be involved in collagen binding (Wienke et al., 2003).
There is no electron density for residues 101–104 and 137–155
in the ricin-like domain and residues 364–378 in the CTL1-
CTL2 linker. The relative arrangement of the two CTL domains
shown in Figure 1B is the only plausible one given the limitations
imposed by the length of the linker. Furthermore, the same over-
all structure is seen in two independent crystal forms and also in
solution (see below). The inter-domain interfaces are sizable
(ricin-FN2, 552 A˚2; FN2-CTL1, 674 A˚2; CTL1-CTL2, 662 A˚2), sug-
gestive of a stable arrangement with limited inter-domains
Figure 2. Comparison of the Ricin-like Domains of Endo180 and MR
The ricin-like domains of (A) Endo180 and (B) MR (Liu et al., 2000) are shown in
the same orientation. The disordered loop regions in Endo180 are indicated by
dotted lines. The 4-SO4-GalNAc molecule bound to MR is shown in atomic
detail.
Figure 3. C-Type Lectin Domains 1 and 2 of Endo180
(A) Superposition of CTL2 of Endo180 (green) with rat mannose-binding pro-
tein bound to an oligomannose ligand (wheat) (Weis et al., 1992). The Endo180
CTL1 domain is shown in pink. Sodium and calcium ions are shown as cyan
and wheat-colored spheres, respectively.
(B) The CTL1-CTL2 interface in Endo180. CTL1 and CTL2 are shown in pink
and green, respectively. Selected residues are shown as sticks.flexibility. The D1-4 region contains five predicted N-linked
glycosylation sites. We observed weak electron density for the
glycans at Asn69 and Asn497; the glycosylation sites at
Asn102, Asn140, and Asn364 are located in the disordered
loop regions mentioned above.
The ricin-like domain of Endo180 (residues 41–174) consists
of eight antiparallel b strands arranged in two sheets. The six
cysteines form three disulfide bonds: 54–68, 93–112, and
123–168. Compared with the regular b trefoil of the homologous
domain in MR (Liu et al., 2000), the ricin-like domain of Endo180
lacks four b strands corresponding to one leaf of the trefoil (Fig-
ure 2). Their space is taken up by an orthogonal a helix, which
contributes three critical leucines (Leu126, Leu130, and
Leu134) to the hydrophobic core. The structural differences be-
tween MR and Endo180 in this region are intriguing given that
the two domains share 29% sequence identity (Figure S1).
The ricin-like domain of MR binds sulfated carbohydrates, and
a co-crystal structure with 4-SO3-GalNAc revealed that the
galactose ring stacks against Trp117 (Liu et al., 2000). This res-
idue is replaced by Ser155 in Endo180. MR residues interacting
with the sulfate group are also not conserved in Endo180, ex-
plaining the lack of sulfated carbohydrate binding to Endo180
(East et al., 2002).
The FN2 domain, the most conserved domain among mem-
bers of the C-type MR family, spans residues 175–231 and con-
tains four cysteines forming two disulfide bonds: 187–213 and
201–228. The FN2 fold consists of two perpendicular b sheets,
each made from two antiparallel strands, and a number of
loops. These elements form a solvent-accessible depression
rich in aromatic residues, which in other FN2-containing pro-
teins have been demonstrated to be involved in gelatin binding
(Figure S2) (Briknarova et al., 1999; Erat et al., 2013; Xu et al.,
2009). Additional binding determinants are provided by the pro-
truding loop connecting the two b sheets (Ju¨rgensen et al.,
2014).
The CTL domains 1 and 2 of Endo180 are very similar to each
other (rmsd of 1.5 A˚ for 125 equivalent Ca atoms) and to other
CTL domains (see below). The CTL fold is characterized by
two three-stranded antiparallel b sheets (b1-b2-b6 and b3-b4-
b5) with two flanking a helices inserted between b2 and b3
(Weis et al., 1998). Each Endo180 CTL domain contains the
conserved pair of nested disulfide bonds (266–359 and 335–
351 in CTL1, 410–504 and 481–496 in CTL2) and a third N-termi-Strunal disulfide bond (235–248 in CTL1 and 382–393 in CTL2). The
40 residues between b3 and b4 are folded into elaborate loop
structures that contain the canonical Ca2+-binding sites of CTL
domains (Weis et al., 1998). No Ca2+ ions were present in our
crystallization solution, but we observed electron density for a
metal ion (most likely Na+) in each CTL domain in a position cor-
responding to the canonical Ca2+ ‘‘site 2’’ (Weis et al., 1998). Na+
binding to a CTL domain has been observed previously (Fein-
berg et al., 2013). The Na+ ions in Endo180 are coordinated by
Gln326, Asp328, Glu333, and Asn348 in CTL1, and by Glu470,
Asn472 and Asp493 in CTL2. Comparison with a typical Ca2+-
loaded CTL domain structure (Figure 3A) suggests that the
Endo180 D1-4 crystal structure is unlikely to change much
upon Ca2+ binding.
The CTL1 and CTL2 domains interact via their elaborate Ca2+-
binding loops. The substantial domain interface (662 A˚2) is domi-
nated by hydrophobic residues, most prominently by Leu317,
Leu320, and Trp322 from CTL1 and Phe453, Trp466, Pro471,
and Phe474 from CTL2 (Figure 3B). These residues come from
equivalent regions in the two CTL domains, and the CTL1-
CTL2 arrangement indeed displays approximate two-fold
symmetry.cture 23, 2133–2142, November 3, 2015 ª2015 The Authors 2135
Figure 4. Small-Angle X-Ray Scattering Analysis of Endo180 D1-4
(A) Experimental data and derived RG and Dmax values at four different buffer
conditions, as indicated. The pH 5.5 + EDTA data are obscured by the pH 7.5 +
Ca2+ data.
(B) Fit of back-calculated curves to the pH 7.5 + Ca2+ data. The cyan and
orange curves were computed, respectively, from the crystal structure and an
all-atom model with added loops and glycans (Guttman et al., 2013).
(C) Best-fit model from (B) superimposed on the ab initio bead model (Franke
and Svergun, 2009) calculated from the pH 7.5 + Ca2+ data. The two views are
related by a 90 rotation about the vertical axis.
Figure 5. Collagen Binding by Endo180 D1-4
(A) Solid-phase assay of D1-4-Fc binding to immobilized type I collagen and
gelatin (heat-denatured type I collagen). The data shown are representative of
five independent experiments carried out in duplicate. For derived KD values,
see the text. Endo180 D1-4-Fc binding to an uncoated control surface is
negligible.
(B) SPR analysis of D1-4-Fc (dimer) and D1-4-His (monomer) binding to im-
mobilized type I collagen and gelatin. The data shown are representative of two
independent experiments. For derived KD values, see the text.
Unless indicated otherwise, the experiments were done at pH 7.5. See also
Figure S3.Solution Structure of Endo180 D1-4
Given that we did not observe electron density for the CTL1-
CTL2 linker in the Endo180 D1-4 crystal structure, we wanted
to confirm the domain arrangement in solution. Because pH-
dependent conformational changes in the Endo180 D1-4 region
were observed by electron microscopy (Boskovic et al., 2006),
we performed small-angle X-ray scattering (SAXS) experiments
with Endo180 D1-4 at pH 7.5 and 5.5, in the presence and
absence of Ca2+. The scattering curves obtained at these condi-
tions were very similar, as were the derived RG and Dmax values
(Figure 4A). A SAXS curve back-calculated from the crystal
structure using FoXS (Schneidman-Duhovny et al., 2010) did
not give a good fit to the experimental data, but an excellent fit
was obtained once the missing loops and glycans were added
to the model (Guttman et al., 2013) (Figure 4B). The resulting
model of glycosylated Endo180 D1-4 agrees well with the low-
resolution shape reconstructed ab initio from the SAXS data (Fig-
ure 4C). The SAXS experiments demonstrate that the Endo180
D1-4 crystal structure is representative of the solution structure
at physiological pH and in the presence of Ca2+. Moreover,
they failed to detect any large conformational changes between
pH 5.5 and pH 7.5.
Identification of the Collagen-Binding Site
Previous studies established that Endo180 binds not only to tri-
ple-helical collagens, but also to denatured collagen (gelatin)
(Martinez-Pomares et al., 2006; Wienke et al., 2003). Endo180
binding to native or denatured type collagen I does not require
Ca2+, whereas there is a Ca2+-dependent enhancement of bind-2136 Structure 23, 2133–2142, November 3, 2015 ª2015 The Authoring to the more highly glycosylated type IV collagen (Ju¨rgensen
et al., 2011). We performed solid-phase binding experiments
with immobilized type I collagen, with and without heat denatur-
ation of the collagen prior to coating. In the solid-phase assay, a
dimeric Fc-tagged Endo180 D1-4 construct bound to gelatin
substantially better than to native collagen (gelatin: KD = 0.42 ±
0.03 mM, Bmax = 1.90 ± 0.03 optical density [OD]; collagen:
KD = 2.5 ± 0.25 mM, Bmax = 0.34 ± 0.02 OD) (Figure 5A), and
this behavior was the same in the presence or absence of Ca2+
(Figure S3). In surface plasmon resonance (SPR) experiments,
the dimeric D1-4-Fc construct bound to gelatin and collagen
with essentially identical KD values of 4.5 ± 0.65 and 4.0 ±
0.60 mM, respectively, and a monomeric His-tagged construct
also discriminated little between gelatin and collagen (KD values
of 17 ± 3.5 and 13 ± 2.4 mM, respectively) (Figure 5B). Thus, the
parameters of the interaction are sensitive to the mode of ligand
presentation, as might be expected for a complex ligand such as
(denatured) collagen. The relatively weak collagen bindings
Figure 6. Mapping of the Collagen-Binding Site of Endo180 D1-4
(A) Solid-phase assay of Fc-tagged Endo180 proteins binding to immobilized gelatin. All proteins were tested at a fixed concentration of 1 mM. The data are
mean ± SE (n = 3). The Coomassie blue-stained SDS-PAGE gel shows the proteins used in the assay, with the positions of the 100- and 60-kDamarkers indicated
on the left.
(B) SPR analysis of Fc-tagged Endo180 proteins binding to immobilized gelatin. Raw sensorgrams are shown for five concentrations (2, 1, 0.5, 0.25 and 0.125 mM)
and a buffer injection.
(C) Solid-phase assay of Endo180D3-4-Fc binding to immobilized type I collagen and gelatin. TheKD values derived from the fits are 3.7 ± 0.43 and 2.2 ± 0.15 mM,
respectively. Endo180 D3-4-Fc binding to an uncoated control surface is negligible.
(D) Point mutations mapped onto the Endo180 D1-4 crystal structure (domains colored as in Figure 1B): red, mutation to alanine reduces collagen binding;
magenta, mutation to an N-linked glycosylation site reduces collagen binding; gray, mutation to alanine has no effect on collagen binding; orange, mutation to
alanine abolished protein secretion.
See also Figure S4.observed in SPR is consistent with previous qualitative observa-
tions (Ju¨rgensen et al., 2014; Martinez-Pomares et al., 2006;
Napper et al., 2006; Wienke et al., 2003). Finally, we used SPR
to show that Endo180 D1-4-Fc binds to gelatin equally well at
neutral pH and at pH 5.5, a condition representing the acidic
environment within endosomes (Figure 5B).
Previous studies showed that the D1-3 region of Endo180
contains all the binding determinants for type I collagen (Ju¨rgen-
sen et al., 2011). To assess the contributions of individual
Endo180 domains to collagen/gelatin binding, we successively
deleted domains from the N terminus. For these experimentsStruwe used Fc-tagged constructs because of their higher sensi-
tivity, and to allow comparison between the two binding assays.
Deletion of the ricin-like domain (D2-4-Fc construct) did not
affect binding in the solid-phase assay (Figure 6A) or in SPR (Fig-
ure 6B). Deletion of both the ricin-like and FN2 domain (D3-4-Fc
construct) reduced binding, but did not abolish it, indicating a
contribution of CTL1 to collagen binding. Notably, the D3-4-Fc
construct showed slower on and off rates in SPR compared
with the step profiles observed with D1-4-Fc (Figure 6B), and it
discriminated less between collagen and gelatin in the solid-
phase assay (Figure 6C).cture 23, 2133–2142, November 3, 2015 ª2015 The Authors 2137
To identify collagen/gelatin-binding residues in the context of
an intact Endo180D1-4 structure, we generated 11mutants (Fig-
ure 6D). Five mutations targeted residues in the FN2 domain
whose counterparts in other FN2 domains are known to be
important for gelatin binding (Briknarova et al., 1999; Mikhailova
et al., 2012; Xu et al., 2009): Y193A, R206A/D208A, Y219A,
W225A, and F227A (R206 and D208 were mutated together, as
they form a salt bridge). The first three mutants were secreted
by HEK293 cells, indicating correct folding. In support of this
notion, mutation of residues analogous to Tyr193 and Arg206
did not perturb the FN2 fold in MMP-2 (Xu et al., 2009). Gln179
was targeted, as it is located within a loop of the Endo180 FN2
domain close to the interface with CTL1; this residue was
mutated to Ala and to a sequon for N-linked glycosylation
(Q179N/N181T). Finally, wemutated three hydrophobic residues
in the CTL1 domain that are on the same face of the Endo180
structure as the presumed gelatin-binding site in the FN2
domain: F253A, L288A, and Y292A. We also introduced a se-
quon for glycan N-linked glycosylation at position 292 (Y292N/
S294T). The engineered glycans at position 179 and 292 were
indeed incorporated, as evidenced by a shift to higher mass on
SDS-PAGE (Figure 6A).
Four Endo180 mutations essentially abolished binding to
gelatin in the solid-phase assay: Y193A, R206A/D208A,
Y219A, and Q179N/N181T (Figure 6A). They include FN2 resi-
dues suspected to be involved in binding (Tyr193, Arg206,
Asp208, Tyr219), as well as a residue closer to the adjoining
CTL1 domain, Gln179. Given that a bulky glycan at position
179 was required to abolish gelatin binding (the Q179A mutant
did bind to gelatin), Gln179 is unlikely to make an essential direct
contact with the collagen chain(s), unlike the aforementioned
residues. Of the mutations in the CTL1 domain, only the engi-
neered glycan at position 292 reduced gelatin binding. Very
similar results were obtained with SPR, both for gelatin (Fig-
ure 6B) and native collagen (data not shown). From the collective
data, we conclude that collagen/gelatin binds primarily to the ca-
nonical ligand-binding site of the FN2 domain, but that additional
contacts are likely to be made with the extended FN2-CTL1 sur-
face (Figures 6D and S4). The effect of the engineered glycan at
position 292 could be due to sterical hindrance of collagen bind-
ing exclusively to the FN2 domain, but this interpretation would
not explain the significant residual collagen binding of the D3-
4-Fc construct, which lacks the FN2 domain.
DISCUSSION
Our crystal structure of the D1-4 region of Endo180 affords the
first detailed view of the collagen-binding site of C-type MRs.
The critical FN2 domain is revealed to be integrated into a seem-
ingly rigid L-shaped structure that allows the adjacent CTL1
domain to participate in collagen binding. This finding is in agree-
ment with a recent biochemical study, which showed that trans-
fer of a functional FN2 domain from Endo180 was not sufficient
to enable collagen internalization by the C-type MR family mem-
bers PLA2R and DEC-205 (Ju¨rgensen et al., 2014). Presumably,
differences within the putative collagen-binding trench in CTL1
(or within the FN2-CTL1 interface) account for the failure of the
chimeric proteins to bind collagen. A comparison of FN2 do-
mains shows that the critical collagen-binding residues of2138 Structure 23, 2133–2142, November 3, 2015 ª2015 The AuthorEndo180 are conserved in MR (Figure S1), consistent with the
established role of MR in collagen uptake (Madsen et al.,
2013). DEC-205 lacks critical collagen-binding determinants of
Endo180 (Tyr193, Arg206, Asp208), but we can see no obvious
reason why PLA2R should not bind collagen. Indeed, collagen
binding by the FN2-CTL1-CTL2 region of PLA2R has been re-
ported in another study (Takahashi et al., 2015). Ca2+-dependent
carbohydrate binding to the CTL2 domain augments binding of
glycosylated type IV collagen to Endo180, whereas this effect
was not observed with the less extensively glycosylated type I
collagen (Ju¨rgensen et al., 2011). Given the large distance be-
tween the binding sites for the collagen backbone and carbohy-
drates in Endo180, the enhanced binding of glycosylated
collagen more likely results from cooperation of multiple recep-
tors than from two-point binding by a single receptor.
MR and Endo180 are unique among FN2-containing proteins
in that they bind not only gelatin but also triple-helical collagen.
MMP-2 contains three FN2 domains that bind gelatin coopera-
tively with aKD of 10 mM (Banyai et al., 1994). The gelatin-binding
sites of the three FN2 domains (Briknarova et al., 1999; Xu et al.,
2009) do not form a contiguous surface in the crystal structure of
pro-MMP-2 (Morgunova et al., 1999), suggesting that a cooper-
ative interaction is only possible with the more flexible single
chains of gelatin and not with the rigid triple helix of native
collagen. The gelatin-binding region of fibronectin consists of
two FN2 domains flanked by fibronectin type I (FN1) domains,
6FN1-1FN2-2FN2-8FN1-9FN1. Structural and biophysical studies
with collagen-derived peptides have shown that a single
collagen chain forms an antiparallel b strand on the outside of
the 8FN1-9FN1 pair (Erat et al., 2009) and may simultaneously
contact the canonical gelatin-binding sites of the 1FN2-2FN2
pair (Erat et al., 2013). As in MMP-2, the ligand-binding mode
is not compatible with a triple-helical collagen structure. In
contrast, the collagen-binding trench spanning the FN2 and
CTL1 domains in Endo180 seems uniquely suited for accommo-
dating triple helices as well as single chains.
The binding site(s) for Endo180 in collagen are unknown.
Given that Endo180 appears to function as a clearance receptor
for cleaved and denatured collagen (see Introduction), it intui-
tively seems more likely that it recognizes some generic feature
of a collagen-derived polypeptide rather than a specific
sequence. Indeed, binding studies provide some evidence for
multiple Endo180-binding sites in type I collagen. In our SPR ex-
periments with immobilized collagen, we observed relatively
weak Endo180 binding with fast on and off rates, likely repre-
senting a monovalent interaction with single sites. In contrast,
when Endo180 is immobilized at high density and collagen is
flowed over this surface (Ju¨rgensen et al., 2011; Madsen et al.,
2007), the interaction is characterized by slower kinetics and
apparent affinities in the nanomolar range, likely representing a
multivalent interaction of a single triple helix with several recep-
tors. Libraries of triple-helical collagen-derived peptides have
been invaluable in defining binding sites for other collagen re-
ceptors, e.g. the discoidin domain receptors (Carafoli et al.,
2009; Konitsiotis et al., 2008). Interrogating such libraries with
Endo180 may not identify the physiologically relevant binding
sites in denatured collagen, however.
Previous single-particle reconstructions of negatively stained
Endo180 concluded that the ricin-like domain interacts withs
CTL2 at neutral pH, and that this interaction is broken at pH 5.4
(Boskovic et al., 2006; Rivera-Calzada et al., 2003). This interpre-
tation is not consistent with our crystal structure and solution
SAXS data, which reveal a more open structure that does not
substantially change with pH. A recent cryoelectron microscopy
structure of DEC-205 at pH 6 revealed an interaction of the ricin-
like domain with CTL3 (Cao et al., 2015). Inspection of the
Endo180 density obtained from electron microscopy (Rivera-
Calzada et al., 2003) suggests that the domains may have
been incorrectly assigned and that it is CTL3 which interacts
with the ricin-like domain also in Endo180. A single-particle
reconstruction of MR revealed a globular head and an S-shaped
tail, but the resolution was not sufficient to unambiguously
assign the D1-4 region within the head (Boskovic et al., 2006).
Amore extendedMR structure was inferred from analytical ultra-
centrifugation experiments (Napper et al., 2001). DEC-205 and
the avian MR homolog FcRU adopt compact structures at pH
6 and become more extended at higher pH (Cao et al., 2015;
He and Bjorkman, 2011). Conformational changes thus appear
to be a recurring theme in the C-type MR family. Although we
cannot exclude that the inter-domain interfaces in our Endo180
D1-4 structure might be broken under certain conditions, we
think it more likely that the D1-4 region behaves as a rigid
collagen-bindingmodule inMR and Endo180, with the remaining
six CTL domains providing the flexibility for any large-scale
structural changes. Limited trypsin digestion of MR indicated
stable association of CTL1-2, CTL4-5, and CTL7-8 (Napper
et al., 2001). It is tempting to speculate that these stable pairs
resemble the head-to-head arrangement of CTL1-2 in our
Endo180 crystal structure and that the pairs are linkedmore flex-
ibly by the intervening domains, CTL3 and CTL6.
Structural changes in the MR and Endo180 ectodomains may
be relevant for the mechanism of collagen release within endo-
somes, which is unknown. Endocytosed receptors that bind
ligand tightly, such as epidermal growth factor receptor, are
often degraded together with the ligand (Goh and Sorkin,
2013). In contrast, recycling receptors, such as MR and
Endo180, must release their ligand before returning to the
plasma membrane. Commonly the release is accomplished by
mechanisms that disfavor ligand binding at the acidic pH and
low Ca2+ concentration of late endosomes (Andersen and
Moestrup, 2014). For instance, the low-density lipoprotein re-
ceptor structure at low pH revealed an autoinhibited conforma-
tion in which the N-terminal ligand-binding region is folded
back against the membrane-proximal domains (Rudenko et al.,
2002). Collagen binding to MR and Endo180 is not Ca2+-depen-
dent (Ju¨rgensen et al., 2011; Martinez-Pomares et al., 2006), and
we found that collagen binding to Endo180 D1-4 is not dimin-
ished at pH 5.5. Therefore, if there is pH-dependent regulation
of ligand binding to Endo180, it would have to involve regions
outside of D1-4. How collagen is released from internalized
Endo180 is an important question for further study.EXPERIMENTAL PROCEDURES
Expression Vectors
Coding sequences were amplified from a full-length cDNA of human Endo180
(a kind gift from Dr. Clare Isacke, Institute of Cancer Research, London, UK)
and cloned intomodified pCEP-Pu vectors (Kohfeldt et al., 1997). All pCEP-en-Strucoded proteins contain a vector-derived APLA sequence at the N terminus,
and are either untagged or have hexahistidine or immunoglobulin G2 (IgG2)
Fc tags at the C terminus (Hussain et al., 2006). The D1-4 construct comprises
Endo180 residues 35–513 (UniProt: Q9UBG0), the D2-4 construct comprises
residues 172–513, and the D3-4 construct comprises residues 231–513. Point
mutations were introduced with strand-overlap extension PCR. All expression
vectors were verified by DNA sequencing.
Protein Production
Human embryonic kidney HEK293 c18 cells (American Type Culture Collec-
tion) were used for protein production. The cells were grown at 37C with
5% CO2 in DMEM/F12 (Invitrogen) containing 10% fetal bovine serum,
2mMglutamine, 10 U/ml penicillin, 100 mg/ml streptomycin, and 250 mg/ml ge-
neticin. Cells were transfected with the expression vectors using Fugene
(Roche Diagnostics) and selected with 1 mg/ml puromycin (Sigma). Trans-
fected cells were grown to confluence in HYPERFlasks (Corning) or 525-cm2
three-layer flasks (BD Biosciences), washed twice with PBS, and incubated
with serum-free medium for up to 3 weeks with two medium exchanges per
week.
For purification of His-tagged Endo180 D1-4, the filtered serum-free cell cul-
ture supernatant was adjusted to a final concentration of 20 mM Na-HEPES
(pH 7.5) and loaded onto a 5-ml HisTrap Excel column (GE Healthcare) using
an A¨kta Purifier (GE Healthcare). The column was washed with PBS and the
protein was eluted with PBS containing 500 mM imidazole. Fractions contain-
ing protein were concentrated using a Vivaspin centrifugal device (Sartorius)
and further purified on a Superdex 200 10/300 Gl column (GE Healthcare) us-
ing 20 mM Tris-HCl (pH 7.5) and 150 mM NaCl as the running buffer.
The Fc-tagged Endo180 proteins were purified using 1-ml protein A HP col-
umns (GE Healthcare). The columns were washed with PBS and the proteins
were eluted with 100mMcitrate buffer (pH 3.0). The 1-ml fractions were imme-
diately neutralized by mixing with 100 ml of 1 M Tris-HCl (pH 8.5) and dialyzed
against PBS.
For purification of untagged Endo180 D1-4, the serum-free cell culture su-
pernatant was exchanged into 50 mM Na-HEPES (pH 7.5) using a VIVAFLOW
200 cross-filtration device (Sartorius Stedim Biotech). The concentrated solu-
tion was loaded onto a HiTrap DEAE FF column (5 ml, GE Healthcare) and pro-
tein eluted in a stepwise fashion with 50 mM Na-HEPES (pH 7.5) containing
100, 150, 200, 250, and 500 mM NaCl. The fractions eluted by 150 mM NaCl
were combined and further purified on a Superdex 200 10/300 Gl column
(GE Healthcare) using 20 mM HEPES (pH 7.5), 150 mM NaCl, and 10 mM
EDTA as the running buffer.
Crystallization
Screening was done at room temperature by the sitting-drop vapor diffusion
method using 96-well plates (Greiner) and a range of commercial screens
(Hampton Research, Molecular Dimensions). A Mosquito nanoliter robot
(TTP Labtech) was used to set up 200-nl sitting drops. His-tagged Endo180
D1-4 crystallized under a wide range of conditions, but none of the crystals dif-
fracted to high resolution. The best crystals that could be obtained were grown
from an 8-mg/ml protein solution (in 20 mM Tris-HCl [pH 7.5], 150 mM NaCl)
using 100 mM BIS-TRIS-HCl (pH 6.5) and 18% polyethylene glycol mono-
methyl ether 5000 as precipitant. The crystals were harvested in reservoir
solution supplemented with 25% glycerol and flash-frozen in liquid nitrogen.
Crystals of untagged Endo180 D1-4 were grown from a 10-mg/ml protein so-
lution (in 20 mM HEPES [pH 7.5], 150 mM NaCl, 10 mM EDTA) using condition
H5 of the Morpheus screen (Molecular Dimensions), which contains a mixture
of amino acids and polyethylene glycols buffered at pH 7.5. These crystals
were flash-frozen directly from the sitting drops.
Structure Determination
Diffraction data were collected at 100 K at beamlines IO4 and IO4-1 of the Dia-
mond Light Source, Oxfordshire, UK. The data were indexed, integrated,
scaled, and merged with XIA2 (Winter, 2010). The crystals of His-tagged and
untagged Endo180 D1-4 were found to belong to space groups P3221 and
C2, respectively, and each to contain two copies of Endo180 D1-4 in the asym-
metric unit. Both crystal forms exhibited anisotropic diffraction limits (trigonal
crystals: <3.3 A˚ along a* and b*, 4.0 A˚ along c*; monoclinic crystals: <2.5 A˚
along b* and c*, 3.0 A˚ along a*).cture 23, 2133–2142, November 3, 2015 ª2015 The Authors 2139
The monoclinic Endo180 D1-4 structure was solved by molecular replace-
ment using the programPHASER (McCoy et al., 2007). Using the CTL of aggre-
can (PDB: 1TDQ) as a search model, four solutions were found, corresponding
to CTL1 and CTL2 of the two D1-4 copies in the asymmetric unit. The CTLs
were fixed and the FN2 domains placed using the first FN2 domain of fibro-
nectin (PDB: 3M7P) as a search model. Finally, the ricin-like domains were
placed using the ricin-like domain of MR (PDB: 1DQG) as a search model.
Manual rebuilding and refinement were done using Coot (Emsley and Cowtan,
2004) and PHENIX (Adams et al., 2010). The refined monoclinic Endo180 D1-4
structure was used to solve the trigonal crystal form. Figures were generated
using PyMOL (http://www.pymol.org/).
Small-Angle X-Ray Scattering
SAXS data were collected at beamline B21 of the Diamond Light Source over a
momentum transfer range of 0.028 A˚1 < q < 0.403 A˚1 from untagged
Endo180 D1-4 in four different buffers: 20 mM Na-HEPES (pH 7.5), 150 mM
NaCl with either 10 mM EDTA or 5 mM CaCl2; 20 mM Na-MES (2-(N-morpho-
lino)ethanesulfonic acid) (pH 5.5), 150 mM NaCl with either 10 mM EDTA or
5 mM CaCl2. Data were collected from three sequential 2-fold dilutions, start-
ing at the following concentrations: 17 mg/ml (pH 7.5 + EDTA), 10 mg/ml (pH
7.5 + Ca2+), 13 mg/ml (pH 5.5 + EDTA), and 7 mg/ml (pH 5.5 + Ca2+). The data
were analyzed, buffer-subtracted, scaled, and merged using the Scatter soft-
ware package (Forster et al., 2010). RG and Dmax values are given in Figure 4A.
Shape estimation was carried out with DAMMIF/DAMMIN (Franke and Sver-
gun, 2009), as implemented in Scatter. In brief, 20 ab initio models were gener-
ated from each dataset, which were then superimposed and averaged using
DAMAVER. The mean normalized spatial discrepancy values were 0.71 (pH
7.5 + EDTA), 0.68 (pH 7.5 + Ca2+), 0.71 (pH 5.5 + EDTA), and 0.59 (pH 5.5 +
Ca2+). The averaged models from DAMAVER were refined to convergence us-
ing DAMMIN, giving final c values of 0.269 (pH 7.5 + EDTA), 0.372 (pH 7.5 +
Ca2+), 0.309 (pH 5.5 + EDTA), and 0.231 (pH 5.5 + Ca2+). Comparison with
the crystal structure was carried out as described by Guttman et al. (2013).
Solid-Phase Binding Assay
The solid-phasebinding assaywasperformedasdescribedbyLeitinger (2003).
Denatured collagen (gelatin)waspreparedby heating a 1-mg/ml solution of rat-
tail type I collagen (Sigma) in 100 mM acetic acid to 67C for 30 min. Native
collagenandgelatinwere coatedonto flat-bottomed96-well plates (NuncMax-
iSorp) at a concentration of 10 mg/ml in 100 mM Tris-HCl (pH 8.5) and 150 mM
NaCl. Unreacted surfaces were blockedwith PBS containing 0.1mg/ml bovine
milk k-casein (Sigma) and 0.05% Tween 20. For the experiment shown in Fig-
ureS3,PBSwas replacedby20mMNa-HEPES (pH7.5) and150mMNaCl con-
taining either 10 mM EDTA or calcium chloride. Fc-tagged Endo180 proteins
diluted in blocking buffer were added for 2 hr. After washing, bound Endo180
proteins were detected by antihuman IgG antibody conjugated to horseradish
peroxidase (Sigma) and SIGMAFAST OPD solution (Sigma). The plates were
measured at 492 nm using a Tecan Sunrise plate reader. The data were fitted
to a single-site binding model using GraphPad Prism.
Surface Plasmon Resonance
The experiments were performed with a Biacore 3000 instrument (GE Health-
care), and collagen and gelatin covalently attached to a CM5 sensor chip (GE
Healthcare). A 10-mg/ml solution of collagen in 10 mM citrate buffer (pH 3.2)
(either untreated or heat-denatured as described above) was flowed over
the activated sensor chip surface until a response of 1,500 resonance units
(RU) was reached, and the remaining activated sites were then blocked using
1 M ethanolamine (pH 7.0). A reference surface was prepared in the same way
without collagen.
The experiments were performed in 20 mM Na-HEPES (pH 7.5), 130 mM
NaCl, 5 mM EDTA, 0.005% Tween 20, or with 20 mMNa-MES (pH 5.5) replac-
ing the HEPES buffer. Endo180 proteins were passed over the sensor chip sur-
face at a flow rate of 30 ml/min at concentrations ranging from 0 to 20 mM for
wild-type D1-4 proteins and from 0 to 2 mM for all other proteins. After each in-
jection, the surfaces were regenerated using a brief pulse of 2Mguanidine-HCl
(pH 7.0). To confirm that this treatment did not denature the collagen surface,
wemeasured binding of a recombinant SPARCprotein that recognizes only tri-
ple-helical type I collagen (Giudici et al., 2008; Hohenester et al., 2008).
Steady-state RU values were obtained using BIAevaluation software (GE2140 Structure 23, 2133–2142, November 3, 2015 ª2015 The AuthorHealthcare). The data were fitted to a single-site binding model using Graph-
Pad Prism.
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